Chemed Q3 diluted EPS climbs 22% to $5.45
CHE•Chemed’s third-quarter 2026 GAAP diluted EPS rose 22% year over year to $5.45, while revenue climbed 11% to $690.9 million.
1. Quarterly results
Chemed’s third-quarter 2026 GAAP diluted earnings per share rose 22% year over year to $5.45, and revenue increased 11% to $690.9 million. During the quarter, Roto-Rooter reacquired California franchise territories for approximately $62.5 million, covering more than 12 million people.
